13. In vivo imaging of vasculature and amyloid plaques in AD mouse models amyloid plaques in AD mouse models plaques labeled by methoxy-X04 vasculature with intravenous dye injection Aged APPswe/PS1 mice with craniotomies
14. Dye labels blood plasma, but not blood cells, allowing identification of flowing vs. stalled vessels
15. Fraction of capillaries with stalled blood flow increased to ~2% in mouse models of AD Temporary stalls that shift between capillary segments, rather than permanent occlusions 2843 capillaries in 6 AD mice 2475 capillaries in 4 WT mice
16. Labeling to distinguish red blood cells, leukocytes, and thrombi as potential cause of stalls leukocytes: rhodamine-6G and Hoechst thrombi: rhodamine-6G red blood cells: unlabeled
17. In vivo imaging of capillary stalls with rhodamine-6G and Hoechst labeling red - Texas-Red dextran green - rhodamine 6G blue - methoxy-X04 and Hoescht
19. How does a single stalled capillary affect blood flow? affect blood flow? N. Nishimura, et al., Nature Methods 3, 99 (2006) Laser injury to vessel triggers clotting Map changes in flow after capillary clot baseline flow post-clot flow mm/s
20. A single stalled capillary causes reduced blood flow in multiple downstream vessel branches N. Nishimura, et al., Nature Methods 3, 99 (2006) Post-clot blood flow speed (fraction of baseline)
21. Map of blood vessels and amyloid plaques from AD mouse plaques from AD mouse
26. Increases in number of stalled capillaries causes decreases in average cerebral blood flow 2% of capillaries stalled predicts a 30% decrease in flow compared to controls
27.
28.
29. Cyclic relationship between vascular stalls and AĪ² aggregates as a driver of AD progression leukocyte plugs AĪ² aggregates
33. To occlude a small blood vessel, we optically injure the vessel to initiate endogenous clotting cascade N. Nishimura, et al., Nature Methods 3, 99 (2006)